Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis
Public ClinicalTrials.gov record NCT05785715. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Phase 2 Induction Study With Long-Term Extension to Evaluate the Clinical Activity and Safety of Oral NX-13 in Participants w/ Moderate to Severe Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Phase 2 induction study with a long-term extension (LTE) period in participants with moderate to severe ulcerative colitis (UC).
Study identification
- NCT ID
- NCT05785715
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 81 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 24, 2023 (Actual)
- Primary completion
- May 30, 2025 (Actual)
- Completion
- May 30, 2025 (Actual)
- Last update posted
- Jun 15, 2026
2023 – 2025
United States locations
- U.S. sites
- 11
- U.S. states
- 6
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Miami Clinical Research | Miami | Florida | 33155 | — |
| Orlando Health, Inc. | Orlando | Florida | 32806 | — |
| GCP Clinical Research | Tampa | Florida | 33609 | — |
| Digestive Health Center of Michigan | Chesterfield | Michigan | 48047 | — |
| Clinical Research Institute of Michigan | Troy | Michigan | 48098 | — |
| Washington University School of Medicine in St. Louis | St Louis | Missouri | 63110 | — |
| Digestive Disease Specialist, Inc-INTEGRIS Baptist Medical Center | Oklahoma City | Oklahoma | 73112 | — |
| Digestive Health Associates of Texas-GI Alliance Research-Garland | Garland | Texas | 75044 | — |
| Digestive Health Associates of Texas-GI Alliance | Mansfield | Texas | 76003 | — |
| Texas Digestive Disease Consultants-GI Alliance Research | Southlake | Texas | 76092 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05785715, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 15, 2026 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05785715 live on ClinicalTrials.gov.